Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C
NCT00433108
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Hepatitis C
Interventions
DRUG:
Mitoquinone mesylate (MitoQ)
Sponsor
Antipodean Pharmaceuticals, Inc.